October 07, 2022
An Ohio federal judge on Friday gave her final approval to a $124 million deal Cardinal Health Inc.'s directors and investors reached to settle a shareholder derivative suit alleging the directors failed to protect the health care services company from liability in the wake of the opioid crisis.
May 26, 2022
Directors of Cardinal Health Inc. and the company's investors have reached a $124 million settlement resolving claims of a shareholder derivative suit that the directors failed to protect the company from liability in the opioid crisis.
February 08, 2021
An Ohio federal judge on Monday cut in half an investors' suit alleging the directors of Cardinal Health Inc. failed to protect the company from liability in the opioid crisis, allowing claims that the directors turned a blind eye to red flags, but tossing out claims they overpaid themselves at the same time.
September 24, 2019
The board of directors of pharmaceutical distributor Cardinal Health Inc. has urged an Ohio federal judge to toss an activist shareholder's derivative suit related to the opioid crisis, saying it was similar to suits that have already been discarded in two Ohio courts, one federal and one state.